Organ differences in microsomes and cytosol metabolism of aflatoxin B1 in piglets

Toxicological and Environmental Chemistry

Volumn 88, Issue 3, 2006, Pages 479-487

  Tulayakul, Phitsanu ^a   Dong, Kesu ^a   Kumagai, Susumu ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aflatoxin B1; Aldehyde reductase; DNA adduct; Glutathione S transferase

Indexed keywords

BIOLOGICAL ORGANS; BIOMEDICAL ENGINEERING; CELLS; DNA; MEDICAL APPLICATIONS; METABOLISM;

AFLATOXIN B1; ALDEHYDE REDUCTASE; DNA ADDUCT; GLUTATHIONE-S-TRANSFERASE;

TOXIC MATERIALS;

BIOASSAY; FUNGUS; METABOLISM; PIG; TOXIN;

EID: 33746873653     PISSN: 02772248     EISSN: 10290486     Source Type: Journal    
DOI: 10.1080/02772240600662203     Document Type: Article

References (32)

1. Anzenbacher P, Souĉek P, Anzenbacherovǎ E, Gut I, Hrubý K, Svoboda Z, Květina J. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes: Comparison with human and liver samples. Drug Metab. Dispos. 1998;26:56-59.
2. Bammler TK, Slone DH, Eaton DL. Effects of dietary oltipraz and ethoxyquin on aflatoxin B1 biotransformation in non-human primates. Toxicol. Sci. 2000;54:30-41.
3. Bennett JW, Klich M. Mycotoxin. Clin. Microbiol. Rev. 2003;16:497-516.
4. Buchi G, Spitzner D, Paglialunga S, Wogan GN. Synthesis and toxicity evaluation of aflatoxin P1. Life Sci. 1973;13:1145.
5. Cole RJ, Schweikert, MA. editors. Aflatoxins. Handbook of Secondary Fungal Metabolites. Vol. I. London: Academic Press; 2003. pp 545-567.
6. Donato MT, Castell JV, José Gómez-Lechón M. Characterization of drug metabolizing activities I pig hepatocytes for use in bioartificial liver devices: Comparison with other hepatic cellular models. J. Hepatol. 1999;31:542-549.
7. Esaki H, Kumagai S. Glutathione-S-transferase activity toward aflatoxin epoxide in livers of mastomys and other rodents. Toxicon. 2002;40:941-945.
8. Gallagher EP, Kunze KL, Stapleton PL, Eaton DL. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol. Appl. Pharmacol. 1996;141:595-606.
9. Guengerich FP, Cai H, Mcmahon M, Hayes JD, Sutter TR, Groopman JD, Deng Z, Harris TM. Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases. Chem. Res. Toxicol. 2001;14:727-737.
10. Harvey RB, Huff WE, Kubena LF, Corrier DE, Phillips TD. Progression of aflatoxicosis in growing barrows. Am. J. Vet. Res. 1988;49:482-487.
11. Hayes JD, Judah DJ, Neal GE. Resistance to Aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res. 1993;53:3887-3894.
12. Hsieh D. Potential human health hazards of mycotoxins. In: Natori S, Hashimoto K, Ueno Y, editors. Mycotoxins and phytotoxins. Third Joint Food and Agriculture Organization/W.H.O./United Nations Program International Conference of Mycotoxins. Amsterdam: Elsevier; 1988.
13. Hsieh DP, Salhab AS, Wong JJ, Yang SL. Toxicity of aflatoxin Q1 as evaluated with the chick embryo and bacterial auxotrophs. Toxicol. Appl. Pharmacol. 1974;30:237-242.
14. International Agency for Research of Cancer (IARC). Aflatoxins: B1, B2, G1, G2, M1. In: Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 56. Lyon: International Agency for Research of Cancer; 1993. pp 245-395.
15. Joint FAO/WHO Expert Committee on Food Additive (JECFA). In Evaluation of certain mycotoxins in food. The fifty-sixth report of the joint FAO/WHO expert committee on food additives (JECFA), WHO technical report series 906, Geneva: World Health Organization; 2002. pp 8-16.
16. Kono M, Kumagai S. In vitro microsome-mediated aflatoxin B1-DNA binding and its inhibition by cytosol of various organs of the hamster and quail. Mycopathologia. 1995;132:117-119.
17. Larsson P, Tjalve H. Bioactivation of Aflatoxin B1 in the nasal and tracheal mucosa in swine. J. Anim. Sci. 1996;74:1672-1680.
18. Marin DE, Taranu I, Bunaciu RP, Pascale F, Tudor DS, Avram N, Sarca M, Cureu I, Criste RD, Suta V, Oswald IP. Change in performance, blood parameters, humoral and cellular immune responses in weanling piglets exposed to low doses of aflatoxin. J. Anim. Sci. 2002;80:1250-1257.
19. Mclean M, Dutton MF. Cellular interactions and metabolism of aflatoxin: An update. Pharmacol. Ther. 1995;65:163-192.
20. Miller DM, Crowell WA, Stuart BP. Acute aflatoxicosis in swine: Clinical pathology, histopathology, and electron microscopy. Am. J. Vet. Res. 1982;43:273-277.
21. Norred WP. Occurrence and clinical manifestations of aflatoxicosis. In: Richard JL, Thurston JR, editors. Diagnosis of mycotoxicoses. Dordrecht: Martinus Nijhoff Publishers; 1986. pp 11-29.
22. Purchase IFH. Acute toxicity of Aflatoxins M1 and M2 in one day old duckling. Food Cosmet. Toxicol. 1967;5:339-344.
23. Ramsdell HS, Eaton DL. Species susceptibility to Aflatoxin B1 carcinogenesis: Comparative kinetics of microsomal biotransformation. Cancer Res. 1990;50:615-620.
24. Raney KD, Meyer DJ, Ketterer B, Harris TM, Guengerich FP. Glutathione conjugation of aflatoxin B1 exo and endo epoxides by rat and human glutathione S-transferase. Chem. Res. Toxicol. 1992;5:470-478.
25. Schultz M, Dutta S, Tew KD. Inhibitors of glutathione-S-transferases as therapeutic agents. Adv. Drug Deliv. Rev. 1997;26:91-104.
26. Shimada T, Guengerich FP. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci., USA 1989;86:462-465.
27. Tulayakul P, Sakuda S, Dong KS, Kumagai S. Comparative activities of glutathione-S-transferase and dialdehyde reductase toward aflatoxin B1 in livers of experimental and farm animal. Toxicon. 2005;46:204-209.
28. Ueng YF, Shimada T, Yamazaki H, Guengerich FP. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 1995;8:218-225.
29. van Iersel MLPS, Ploemen JHTM, Bello ML, Federici G, van Bladeren PJ. Interactions of α,β-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chem. Biol. Interact. 1997;108:67-78.
30. Wild CP, Turner PC. The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis 2002;17:471-481.
31. Wong ZA, Hsieh DP. The comparative metabolism and toxicokinetics of aflatoxin B1 in the monkey, rat, and mouse. Toxicol. Appl. Pharmacol. 1980;55:115-125.
32. Yanagimoto T, Susumu T, Sawada M, Hashimoto H, Kamataki T. Molecular cloning and functional expression of a mouse cytochrome P-450(CYP 3a-13): Examination of CYP 3a-13 enzyme to activate aflatoxin B1(AFB1). Biochem. Biophys. Acta 1994;1201:405-410.